Dynavax Technologies Corp (DVAX)
11.02
-0.17
(-1.52%)
USD |
NASDAQ |
Oct 04, 16:00
10.91
-0.11
(-1.00%)
After-Hours: 20:00
Dynavax Technologies Shareholders Equity (Annual): 622.07M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 622.07M |
| December 31, 2022 | 581.01M |
| December 31, 2021 | 222.37M |
| December 31, 2020 | 58.69M |
| December 31, 2019 | 8.29M |
| December 31, 2018 | 63.06M |
| December 31, 2017 | 199.55M |
| December 31, 2016 | 89.20M |
| December 31, 2015 | 187.08M |
| December 31, 2014 | 100.48M |
| December 31, 2013 | 186.29M |
| December 31, 2012 | 114.83M |
| Date | Value |
|---|---|
| December 31, 2011 | 99.88M |
| December 31, 2010 | 52.11M |
| December 31, 2009 | 6.376M |
| December 31, 2008 | 13.52M |
| December 31, 2007 | 30.79M |
| December 31, 2006 | 77.06M |
| December 31, 2005 | 74.36M |
| December 31, 2004 | 59.88M |
| December 31, 2003 | -71.93M |
| December 31, 2002 | -56.37M |
| December 31, 2001 | -34.42M |
| December 31, 2000 | -18.00M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
8.29M
Minimum
2019
622.07M
Maximum
2023
298.49M
Average
222.37M
Median
2021
Shareholders Equity (Annual) Benchmarks
| Biogen Inc | 14.80B |
| Repligen Corp | 1.971B |
| West Pharmaceutical Services Inc | 2.881B |
| XOMA Royalty Corp | 88.72M |
| Xencor Inc | 668.80M |